Analytical validation of a standardized scoring protocol for Ki67: phase 3 of an international multicenter collaboration (Q33915010)

30 July 2017

Analytical validation of a standardized scoring protocol for Ki67: phase 3 of an international multicenter collaboration (English)

1 reference

30 July 2017

1 reference

5

Sunil S Badve

1 reference

30 July 2017

34

Mitch Dowsett

1 reference

30 July 2017

31

Giuseppe Viale

1 reference

30 July 2017

Samuel C Y Leung

1

1 reference

30 July 2017

Torsten O Nielsen

2

1 reference

30 July 2017

Lila Zabaglo

3

1 reference

30 July 2017

Indu Arun

4

1 reference

30 July 2017

Anita L Bane

6

1 reference

30 July 2017

John M S Bartlett

7

1 reference

30 July 2017

Signe Borgquist

8

1 reference

30 July 2017

Martin C Chang

9

1 reference

30 July 2017

Andrew Dodson

10

1 reference

30 July 2017

Rebecca A Enos

11

1 reference

30 July 2017

Susan Fineberg

12

1 reference

30 July 2017

Cornelia M Focke

13

1 reference

30 July 2017

Dongxia Gao

14

1 reference

30 July 2017

Allen M Gown

15

1 reference

30 July 2017

Dorthe Grabau

16

1 reference

30 July 2017

Carolina Gutierrez

17

1 reference

30 July 2017

Judith C Hugh

18

1 reference

30 July 2017

Zuzana Kos

19

1 reference

30 July 2017

Anne-Vibeke Lænkholm

20

1 reference

30 July 2017

Ming-Gang Lin

21

1 reference

30 July 2017

Mauro G Mastropasqua

22

1 reference

30 July 2017

Takuya Moriya

23

1 reference

30 July 2017

Sharon Nofech-Mozes

24

1 reference

30 July 2017

C Kent Osborne

25

1 reference

30 July 2017

Frédérique M Penault-Llorca

26

1 reference

30 July 2017

Tammy Piper

27

1 reference

30 July 2017

Takashi Sakatani

28

1 reference

30 July 2017

Roberto Salgado

29

1 reference

30 July 2017

Jane Starczynski

30

1 reference

30 July 2017

Daniel F Hayes

32

1 reference

30 July 2017

Lisa M McShane

33

1 reference

30 July 2017

18 May 2016

1 reference

30 July 2017

1 reference

30 July 2017

2

1 reference

30 July 2017

16014

1 reference

Creative Commons Attribution 4.0 International

30 July 2017

start time

18 May 2016

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1038/npjbcancer.2016.14

0 references

cites work

Prognostic value of different cut-off levels of Ki-67 in breast cancer: a systematic review and meta-analysis of 64,196 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5515324

Strategies for developing Ki67 as a useful biomarker in breast cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5515324

The role of immunohistochemistry in the evaluation of gynecologic pathology part 2: a comparative study between two academic institutes

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5515324

The Prognostic Role of Ki-67/MIB-1 in Upper Urinary-Tract Urothelial Carcinomas: A Systematic Review and Meta-Analysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5515324

Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5515324

An interobserver reproducibility analysis of Ki67 visual assessment in breast cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5515324

An international study to increase concordance in Ki67 scoring

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5515324

Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypes

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5515324

An international Ki67 reproducibility study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5515324

Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5515324

Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5515324

Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5515324

Ki67 in breast cancer: prognostic and predictive potential

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5515324

Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32,825 patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5515324

Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5515324

Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5515324

The Measurement of Observer Agreement for Categorical Data

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5515324

Use of modified Magee equations and histologic criteria to predict the Oncotype DX recurrence score.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5515324

High Ki-67 score is indicative of a greater benefit from adjuvant chemotherapy when added to endocrine therapy in luminal B HER2 negative and node-positive breast cancer.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5515324

Ki67 levels as predictive and prognostic parameters in pretherapeutic breast cancer core biopsies: a translational investigation in the neoadjuvant GeparTrio trial.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5515324

A prognostic model based on combining estrogen receptor expression and Ki-67 value after neoadjuvant chemotherapy predicts clinical outcome in locally advanced breast cancer: extension and analysis of a previously reported cohort of patients.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5515324

Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the Genomic Health recurrence score in early breast cancer.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5515324

Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5515324

Routine pathologic parameters can predict Oncotype DX recurrence scores in subsets of ER positive patients: who does not always need testing?

29 October 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FNPJBCANCER.2016.14

inferred from DOI database lookup

7 January 2021

based on heuristic

Comparative validation of the SP6 antibody to Ki67 in breast cancer

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FNPJBCANCER.2016.14

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NPJBCANCER.2016.14

1 reference

Dimensions Publication ID

30 July 2017

0 references

1 reference

30 July 2017

1 reference